Document ID: chunk:federal_register_of_legislation:F2025C00217:reg:5
Version: federal_register_of_legislation:F2025C00217
Segment Type: reg
Provision Reference: reg 5
Character Range: 2637–3671

5  Definitions
 (1) In this instrument:
Act means the National Health Act 1953.
base‑priced drug in relation to a brand of a pharmaceutical item mentioned in Schedule 2 (the relevant brand), means all brands of pharmaceutical items that have:
 (a) the same drug as the relevant brand; or
 (b) a drug in the same therapeutic group as that drug;
and for which no price is determined under section 85B of the Act.
pack quantity has the same meaning as in subsection 84(1) of the Act.
Note: The Minister may determine one or more pack quantities for a brand of a pharmaceutical item under subsection 84AK(2) of the Act. The quantities determined are the quantities in a manufacturer's PBS packs.
pricing quantity has the same meaning as in subsection 84(1) of the Act.
Note: Subsection 84AK(1) of the Act provides that the pricing quantity of a brand of a pharmaceutical item is the lowest of any pack quantity of any brand of the pharmaceutical item.
special patient contribution has the same meaning as in subsection 84(1) of the Act.